Physician Assistant in Princeton, IN Accepting Medicare

3 Physician Assistant nurses found. Showing 1 - 3

Christopher Martin Everett, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 4000 Tulip Tree Drive, Industrial Health Services, Princeton, IN 47670 Phone: 812-387-2922    Fax: 812-387-2045

Mr. Rex Andrew Blunck, P.A.-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 4000 Tulip Tree Dr, Ss-i, Princeton, IN 47670 Phone: 812-387-2922    Fax: 812-387-2045

Mr. Jackie David Reeder, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1808 Sherman Drive, Gibson General Hospital, Princeton, IN 47670 Phone: 812-385-9208    Fax: 812-385-9410

News Archive

Express Scripts launches suite of services through HealthBridge Pharma & Biotech

Express Scripts has launched a suite of services for pharmaceutical and biotech companies through HealthBridge Pharma & Biotech, providing a single-solution approach to patient care.

FDA approves first drug for treating rare form of Batten disease

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.

Israeli government and a private investment fund Brainstorm Cell Therapeutics to complete pre-clinical studies in ALS

BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease). The company expects to begin Phase I clinical studies in 2010.

Astex celebrates as breast cancer drug gets European marketing approval

Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.

Read more Medical News

› Verified 6 days ago